EBioMedicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2022-08-13 Yancie JAY

请问各位前辈，如果文章字数超出范围会被直接拒稿吗

0 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2023-12-11 ms1000000959787142 来自天津

各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢

226 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2019-05-11 haiyang0518

审稿速度:1.0 | 投稿命中率:25.0
经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，

302 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2022-10-20 y-y-y

审稿速度:2.0
偏重的研究方向：转化医学;临床转化
经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。

308 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2024-01-17 ms2000000395345853 来自四川省

偏重的研究方向：转化医学
经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢

203 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2023-07-12 guolihuihelan_91618321 来自荷兰

审稿速度:12.0 | 投稿命中率:5.0
经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢

243 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2023-04-19 1de85404m20(暂无匿称) 来自广东省

各位大佬，投稿会给每个作者发邮件吗

221 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2022-11-22 guolihuihelan_91618321

这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利

285 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2023-02-01 ms9000000893151020 来自河北省

各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！

207 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1238468, encodeId=2177123846800, content=请问各位前辈，如果文章字数超出范围会被直接拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0ab2096768, createdName=Yancie JAY, createdTime=Sat Aug 13 13:18:38 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174266, encodeId=54a121e426610, content=各位大佬们，我想问一下这个杂志，Required Reviews Completed这一步大概多久呀，快一个月了，没变化呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Mon Dec 11 14:28:48 CST 2023, time=2023-12-11, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=570750, encodeId=5e1b5e07504d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：20190326投稿，20190410回复一审意见，20190425修回，20190510正式接受，一共45天，很快了，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKuTLzo0HrCp5RQZ4fKPw3icrAGelOfQHYnzrHTyBM5S7iaNGibGB6JLrnicGIauO7fGUKSibz9t14Nf6w/132, createdBy=82c02152739, createdName=haiyang0518, createdTime=Sat May 11 09:13:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095030, encodeId=5ccb209503005, content=审稿速度:2.0 偏重的研究方向：转化医学;临床转化 经验分享：时隔三年有幸再中ebio，过程还算顺利，编辑一如既往的nice，祝愿期刊越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/23/389dc48415662ee39e08e2a072edca25.jpg, createdBy=7a8b2236930, createdName=y-y-y, createdTime=Thu Oct 20 20:19:31 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2182220, encodeId=25432182220b5, content=偏重的研究方向：转化医学 经验分享：投稿后3天变成under review，中途日期变更了两次，但还是under review状态，这是什么原因呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8916149900, createdName=ms2000000395345853, createdTime=Wed Jan 17 16:28:01 CST 2024, time=2024-01-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2147689, encodeId=fa47214e68953, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：PASC, long COVID-19, 审稿9-10个月，真的是熬碎心，收到接收邮件的那一刻感觉还是值得的，PUA的越厉害，就越喜欢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Wed Jul 12 19:04:44 CST 2023, time=2023-07-12, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2127122, encodeId=26bb212e12287, content=各位大佬，投稿会给每个作者发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231102/0c9e5413f4ba4bbdb156bc2a2418ce2e/0236291df9e84588a5c221c5f3033605.jpeg, createdBy=079f1702729, createdName=1de85404m20(暂无匿称), createdTime=Wed Apr 19 21:30:36 CST 2023, time=2023-04-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101887, encodeId=6fac210188ea4, content=这个杂志今年2022一月份成了柳叶刀子刊了，现在跟正苗红了，以后估计会越来越难，感觉得文章质量从今年开始也比以前有了提高，希望一切顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Tue Nov 22 07:32:45 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112503, encodeId=43dc211250314, content=各位前辈，可以求个参考文献e n d n o t e的s t y l e嘛，实在是找不到，万分感谢！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40ee8147704, createdName=ms9000000893151020, createdTime=Wed Feb 01 04:04:25 CST 2023, time=2023-02-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2120615, encodeId=0c662120615b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca8e5514397, createdName=ms3000000696795394, createdTime=Mon Mar 20 19:18:55 CST 2023, time=2023-03-20, status=1, ipAttribution=浙江省)]

2023-03-20 ms3000000696795394 来自浙江省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：呜呜

232 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务